These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35245745)

  • 1. Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia.
    Liu Y; Jia LN; Wu H; Jiang W; Wang Q; Wang D; Xiong YB; Ren YP; Ma X; Tang YL
    Psychiatry Res; 2022 May; 311():114484. PubMed ID: 35245745
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of mismatch negativity and P3a for use in multi-site studies of schizophrenia: characterization of demographic, clinical, cognitive, and functional correlates in COGS-2.
    Light GA; Swerdlow NR; Thomas ML; Calkins ME; Green MF; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Pela M; Radant AD; Seidman LJ; Sharp RF; Siever LJ; Silverman JM; Sprock J; Stone WS; Sugar CA; Tsuang DW; Tsuang MT; Braff DL; Turetsky BI
    Schizophr Res; 2015 Apr; 163(1-3):63-72. PubMed ID: 25449710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of glycine on auditory mismatch negativity in schizophrenia.
    Greenwood LM; Leung S; Michie PT; Green A; Nathan PJ; Fitzgerald P; Johnston P; Solowij N; Kulkarni J; Croft RJ
    Schizophr Res; 2018 Jan; 191():61-69. PubMed ID: 28602646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study.
    Şevik AE; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Gürses N; Yıldız M
    Schizophr Res; 2011 Aug; 130(1-3):195-202. PubMed ID: 21592733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMN responsivity to manipulations of frequency and duration deviants in chronic, clozapine-treated schizophrenia patients.
    Horton J; Millar A; Labelle A; Knott VJ
    Schizophr Res; 2011 Mar; 126(1-3):202-11. PubMed ID: 21194893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mismatch negativity as an index of target engagement for excitation/inhibition-based treatment development: a double-blind, placebo-controlled, randomized, single-dose cross-over study of the serotonin type-3 receptor antagonist CVN058.
    Sehatpour P; Javitt DC; De Baun HM; Carlson M; Beloborodova A; Margolin DH; Carlton MBL; Brice NL; Kantrowitz JT
    Neuropsychopharmacology; 2022 Feb; 47(3):711-718. PubMed ID: 34667294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do ERPs and ERFs reveal about the effect of antipsychotic treatment on cognition in schizophrenia?
    Korostenskaja M; Kähkönen S
    Curr Pharm Des; 2009; 15(22):2573-93. PubMed ID: 19689329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auditory event-related potentials, neurocognition, and global functioning in drug naïve first-episode schizophrenia and bipolar disorder.
    Li X; Deng W; Xue R; Wang Q; Ren H; Wei W; Zhang Y; Li M; Zhao L; Du X; Meng Y; Ma X; Hall MH; Li T
    Psychol Med; 2023 Feb; 53(3):785-794. PubMed ID: 34474699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia.
    Hamilton HK; D'Souza DC; Ford JM; Roach BJ; Kort NS; Ahn KH; Bhakta S; Ranganathan M; Mathalon DH
    Schizophr Res; 2018 Jan; 191():87-94. PubMed ID: 28711472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are auditory-evoked frequency and duration mismatch negativity deficits endophenotypic for schizophrenia? High-density electrical mapping in clinically unaffected first-degree relatives and first-episode and chronic schizophrenia.
    Magno E; Yeap S; Thakore JH; Garavan H; De Sanctis P; Foxe JJ
    Biol Psychiatry; 2008 Sep; 64(5):385-91. PubMed ID: 18472090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment in Mismatch Negativity but not Repetition Suppression in Schizophrenia.
    Coffman BA; Haigh SM; Murphy TK; Salisbury DF
    Brain Topogr; 2017 Jul; 30(4):521-530. PubMed ID: 28516227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex mismatch negativity to tone pair deviants in long-term schizophrenia and in the first-episode schizophrenia spectrum.
    Salisbury DF; McCathern AG; Coffman BA; Murphy TK; Haigh SM
    Schizophr Res; 2018 Jan; 191():18-24. PubMed ID: 28506707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of mismatch negativity (MMN) in schizophrenia patients with auditory hallucinations experiencing acute exacerbation of illness.
    Fisher DJ; Labelle A; Knott VJ
    Schizophr Res; 2012 Aug; 139(1-3):237-45. PubMed ID: 22727705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Frequency Mismatch Negativity in Early Psychosis Outpatient Subjects.
    Del Re EC; Maekawa T; Mesholam-Gately RI; Wojcik J; Seidman LJ; McCarley RW; Niznikiewicz MA
    Clin EEG Neurosci; 2020 Jul; 51(4):207-214. PubMed ID: 31826666
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement in mismatch negativity generation during d-serine treatment in schizophrenia: Correlation with symptoms.
    Kantrowitz JT; Epstein ML; Lee M; Lehrfeld N; Nolan KA; Shope C; Petkova E; Silipo G; Javitt DC
    Schizophr Res; 2018 Jan; 191():70-79. PubMed ID: 28318835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced late mismatch negativity and auditory sustained potential to rule-based patterns in schizophrenia.
    Haigh SM; Coffman BA; Murphy TK; Butera CD; Leiter-McBeth JR; Salisbury DF
    Eur J Neurosci; 2019 Jan; 49(2):275-289. PubMed ID: 30471147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia.
    Hamilton HK; Perez VB; Ford JM; Roach BJ; Jaeger J; Mathalon DH
    Schizophr Bull; 2018 Apr; 44(3):492-504. PubMed ID: 29036701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mismatch Negativity is a Sensitive and Predictive Biomarker of Perceptual Learning During Auditory Cognitive Training in Schizophrenia.
    Perez VB; Tarasenko M; Miyakoshi M; Pianka ST; Makeig SD; Braff DL; Swerdlow NR; Light GA
    Neuropsychopharmacology; 2017 Oct; 42(11):2206-2213. PubMed ID: 28139679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigm.
    McCleery A; Mathalon DH; Wynn JK; Roach BJ; Hellemann GS; Marder SR; Green MF
    Psychol Med; 2019 May; 49(7):1195-1206. PubMed ID: 30642411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of phonetic mismatch negativity may depict illness course and predict functional outcomes in schizophrenia.
    Mi L; Wang L; Li X; She S; Li H; Huang H; Zhang J; Liu Y; Zhao J; Ning Y; Zheng Y
    J Psychiatr Res; 2021 May; 137():290-297. PubMed ID: 33735719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.